The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor--an alternative gene therapy.
about
Bacteria in gene therapy: bactofection versus alternative gene therapy.On the physiology and pathophysiology of antimicrobial peptides.Biological gene delivery vehicles: beyond viral vectors.Emerging biotechnological strategies for non-viral antiangiogenic gene therapy.Microvascular angioadaptation after endurance training with L-arginine supplementation in rat heart and hindleg muscles.
P2860
The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor--an alternative gene therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The use of transformed Escheri ...... --an alternative gene therapy.
@en
The use of transformed Escheri ...... --an alternative gene therapy.
@nl
type
label
The use of transformed Escheri ...... --an alternative gene therapy.
@en
The use of transformed Escheri ...... --an alternative gene therapy.
@nl
prefLabel
The use of transformed Escheri ...... --an alternative gene therapy.
@en
The use of transformed Escheri ...... --an alternative gene therapy.
@nl
P2093
P1433
P1476
The use of transformed Escheri ...... --an alternative gene therapy.
@en
P2093
Dávid Jandzík
Gabriel Minárik
Hana Drahovská
Ingrid Jurkovicová
Ivan Hulín
Ján Jakubovský
Ján Lukács
Lubos Danisovic
Martin Kopáni
P304
P356
10.1016/J.MEHY.2004.07.039
P577
2005-01-01T00:00:00Z